SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19324520
Source:
http://linkedlifedata.com/resource/pubmed/id/19324520
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0034975
,
umls-concept:C0085278
,
umls-concept:C0179586
,
umls-concept:C0205549
,
umls-concept:C0678257
,
umls-concept:C1413079
,
umls-concept:C1413120
pubmed:issue
3-4
pubmed:dateCreated
2009-5-8
pubmed:abstractText
To describe the clinical and laboratory features, as well as the precipitating factors, treatment and outcome of patients with catastrophic antiphospholipid syndrome (APS).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8812164
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antiphospholipid
,
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, Intravenous
,
http://linkedlifedata.com/resource/pubmed/chemical/Steroids
pubmed:status
MEDLINE
pubmed:issn
1095-9157
pubmed:author
pubmed-author:BucciarelliSilviaS
,
pubmed-author:Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group...
,
pubmed-author:CerveraRicardR
,
pubmed-author:EspinosGerardG
,
pubmed-author:Gómez-PuertaJosé AJA
,
pubmed-author:IngelmoMiguelM
,
pubmed-author:PlasínMiguel AMA
,
pubmed-author:PlazaJoanJ
,
pubmed-author:Pons-EstelGuillermoG
,
pubmed-author:ShoenfeldYehudaY
pubmed:issnType
Electronic
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
240-5
pubmed:meshHeading
pubmed-meshheading:19324520-Adolescent
,
pubmed-meshheading:19324520-Adult
,
pubmed-meshheading:19324520-Antibodies, Antiphospholipid
,
pubmed-meshheading:19324520-Anticoagulants
,
pubmed-meshheading:19324520-Antiphospholipid Syndrome
,
pubmed-meshheading:19324520-Catastrophic Illness
,
pubmed-meshheading:19324520-Child
,
pubmed-meshheading:19324520-Female
,
pubmed-meshheading:19324520-Humans
,
pubmed-meshheading:19324520-Immunoglobulins, Intravenous
,
pubmed-meshheading:19324520-Male
,
pubmed-meshheading:19324520-Middle Aged
,
pubmed-meshheading:19324520-Plasma Exchange
,
pubmed-meshheading:19324520-Registries
,
pubmed-meshheading:19324520-Steroids
,
pubmed-meshheading:19324520-Young Adult
pubmed:articleTitle
Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
pubmed:affiliation
Department of Autoimmune Diseases, Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Barcelona, Catalonia, Spain. rcervera@clinic.ub.es
pubmed:publicationType
Journal Article